Benchmark Reaffirms "Buy" Rating for Integer (NYSE:ITGR)

Integer (NYSE:ITGR - Get Free Report)'s stock had its "buy" rating restated by analysts at Benchmark in a research note issued to investors on Friday, Benzinga reports. They currently have a $130.00 price objective on the medical equipment provider's stock. Benchmark's target price would indicate a potential upside of 14.09% from the company's previous close.

Other research analysts have also recently issued research reports about the company. Bank of America upgraded Integer from a "neutral" rating to a "buy" rating and lifted their target price for the company from $105.00 to $135.00 in a research report on Monday, April 15th. KeyCorp lifted their target price on Integer from $123.00 to $139.00 and gave the company an "overweight" rating in a research report on Tuesday, April 9th. Finally, CL King began coverage on Integer in a research report on Thursday, March 14th. They issued a "buy" rating and a $137.00 target price on the stock. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $120.50.

Integer Stock Down 0.2 %

Shares of NYSE:ITGR traded down $0.28 during midday trading on Friday, hitting $113.95. The stock had a trading volume of 206,477 shares, compared to its average volume of 335,044. Integer has a 12 month low of $69.40 and a 12 month high of $123.99. The company has a quick ratio of 2.01, a current ratio of 3.32 and a debt-to-equity ratio of 0.76. The business's 50-day simple moving average is $114.78 and its 200-day simple moving average is $102.36. The company has a market cap of $3.82 billion, a P/E ratio of 39.43, a PEG ratio of 1.65 and a beta of 1.12.

Integer (NYSE:ITGR - Get Free Report) last released its earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share for the quarter, beating the consensus estimate of $1.12 by $0.02. Integer had a net margin of 6.01% and a return on equity of 11.25%. The business had revenue of $414.80 million during the quarter, compared to analysts' expectations of $412.78 million. During the same period last year, the business earned $0.87 earnings per share. The firm's revenue was up 9.5% on a year-over-year basis. On average, sell-side analysts forecast that Integer will post 5.27 earnings per share for the current fiscal year.

Insider Activity

In related news, VP Tommy P. Thomas sold 1,500 shares of the stock in a transaction dated Tuesday, April 30th. The stock was sold at an average price of $114.00, for a total transaction of $171,000.00. Following the sale, the vice president now owns 2,813 shares of the company's stock, valued at approximately $320,682. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, SVP Andrew Senn sold 5,000 shares of the stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $113.14, for a total transaction of $565,700.00. Following the transaction, the senior vice president now directly owns 4,658 shares in the company, valued at approximately $527,006.12. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Tommy P. Thomas sold 1,500 shares of the stock in a transaction dated Tuesday, April 30th. The shares were sold at an average price of $114.00, for a total value of $171,000.00. Following the transaction, the vice president now owns 2,813 shares in the company, valued at $320,682. The disclosure for this sale can be found here. Insiders have sold 6,812 shares of company stock valued at $771,956 in the last 90 days. Insiders own 2.00% of the company's stock.

Hedge Funds Weigh In On Integer

Several institutional investors have recently modified their holdings of ITGR. Blue Trust Inc. increased its position in shares of Integer by 483.3% during the 4th quarter. Blue Trust Inc. now owns 455 shares of the medical equipment provider's stock valued at $45,000 after purchasing an additional 377 shares during the last quarter. Principal Securities Inc. bought a new position in Integer during the 4th quarter worth approximately $67,000. Headlands Technologies LLC bought a new position in Integer during the 1st quarter worth approximately $106,000. Van ECK Associates Corp grew its position in Integer by 22.0% during the 3rd quarter. Van ECK Associates Corp now owns 1,733 shares of the medical equipment provider's stock worth $136,000 after acquiring an additional 313 shares during the last quarter. Finally, Quadrant Capital Group LLC grew its position in Integer by 10.2% during the 4th quarter. Quadrant Capital Group LLC now owns 1,427 shares of the medical equipment provider's stock worth $141,000 after acquiring an additional 132 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.